期刊
CLINICAL NUTRITION ESPEN
卷 31, 期 -, 页码 28-32出版社
ELSEVIER
DOI: 10.1016/j.clnesp.2019.03.006
关键词
Acute lymphoblastic leukemia; Vitamin D; 25-hydroxyvitamin D-3; Insulin resistance; Metabolic syndrome; Lipids
资金
- Institute of Cancer Research of the Canadian Institutes of Health Research
- C17 Council
- Canadian Cancer Society
- Cancer Research Society
- Garron Family Cancer Centre at the Hospital for Sick Children
- Ontario Institute for Cancer Research (OICR)
- Pediatric Oncology Group of Ontario [TCF 118694]
Background: Treatment of childhood acute lymphoblastic leukemia (cALL) has reached unprecedented success leading to survival rates reaching 90%. This is regrettably linked to increased risk of developing long-term health-related sequels into early adulthood. Objective: This study aims at assessing the relationship between the vitamin D status and metabolic biomarkers in PETALE, a well-characterized cohort of cALL survivors. Results: We demonstrate that 15.9% of the study participants exhibited 3 or more metabolic syndrome (MetS) risk factors. We also show a direct relationship between s25OHD(3) and plasma HDL-Cholesterol concentrations in female but not male participants. Conclusion: Our data, from a metabolically well-described cohort, support a modest role for vitamin D in lipid metabolism in childhood leukemia survivors. The major outcome of this study is the strong association between HDL-Cholesterol concentration and s25OHD(3) only in female subjects, thereby conveying vitamin D a gender-specific cardio-protective effect. cALL survivors represent a population at higher risk for secondary diseases. For this reason thorough nutritional evaluation, including vitamin D should be part of the regular follow-up. (C) 2019 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据